Excess Alcohol-Induced Hospitalisations and Deaths During the First Year of the COVID-19 Pandemic in Australia.

IF 3 3区医学 Q2 SUBSTANCE ABUSE

Drug and alcohol review Pub Date : 2025-06-29 DOI:10.1111/dar.14097

Wing See Yuen, Nicola Man, Michael Livingston, Agata Chrzanowska, William Gilmore, Louise Tierney, Lauren Moran, Amy Peacock

{"title":"Excess Alcohol-Induced Hospitalisations and Deaths During the First Year of the COVID-19 Pandemic in Australia.","authors":"Wing See Yuen, Nicola Man, Michael Livingston, Agata Chrzanowska, William Gilmore, Louise Tierney, Lauren Moran, Amy Peacock","doi":"10.1111/dar.14097","DOIUrl":null,"url":null,"abstract":"Introduction: Since the onset of COVID-19, alcohol-related harm has increased in regions such as the United States and the United Kingdom. We examined whether alcohol-related harm increased with the pandemic in Australia, and whether the impact varied across sex, age and type of alcohol diagnosis.Methods: Monthly rates of alcohol-induced hospitalisations and deaths nationally from July 2016 until February 2020 were modelled in an autoregressive integrated moving average analysis, and the counterfactual trend was forecasted until April 2021. We estimated the overall excess in average monthly numbers of alcohol-induced hospitalisations and deaths by sex, age and diagnosis.Results: We found excess monthly alcohol-induced hospitalisations overall (681 [95% prediction interval 481-872]), among males (437 [343-528]), females (208 [50-355]), 15- to 34-year-olds (144 [57-226]), 35- to 54-year-olds (331 [2-636]), for cardiovascular, digestive and endocrine diseases (164 [108-223]) and for neuropsychiatric conditions (483 [236-721]). Excess monthly alcohol-induced deaths were found overall (13 [4-21]), among males (10 [0-19]), females (4 [1-7]), 35- to 54-year-olds (8 [5-11]) and for cardiovascular, digestive and endocrine diseases (10 [2-18]) and poisonings (2 [0-4]).Discussion and conclusions: Increased alcohol-induced hospitalisations and deaths across Australia indicate a need to continue to monitor the long-term impacts of the COVID-19 pandemic and develop strategies to minimise further harm among those currently affected and in the event of future public health crises.","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and alcohol review","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dar.14097","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Since the onset of COVID-19, alcohol-related harm has increased in regions such as the United States and the United Kingdom. We examined whether alcohol-related harm increased with the pandemic in Australia, and whether the impact varied across sex, age and type of alcohol diagnosis.

Methods: Monthly rates of alcohol-induced hospitalisations and deaths nationally from July 2016 until February 2020 were modelled in an autoregressive integrated moving average analysis, and the counterfactual trend was forecasted until April 2021. We estimated the overall excess in average monthly numbers of alcohol-induced hospitalisations and deaths by sex, age and diagnosis.

Results: We found excess monthly alcohol-induced hospitalisations overall (681 [95% prediction interval 481-872]), among males (437 [343-528]), females (208 [50-355]), 15- to 34-year-olds (144 [57-226]), 35- to 54-year-olds (331 [2-636]), for cardiovascular, digestive and endocrine diseases (164 [108-223]) and for neuropsychiatric conditions (483 [236-721]). Excess monthly alcohol-induced deaths were found overall (13 [4-21]), among males (10 [0-19]), females (4 [1-7]), 35- to 54-year-olds (8 [5-11]) and for cardiovascular, digestive and endocrine diseases (10 [2-18]) and poisonings (2 [0-4]).

Discussion and conclusions: Increased alcohol-induced hospitalisations and deaths across Australia indicate a need to continue to monitor the long-term impacts of the COVID-19 pandemic and develop strategies to minimise further harm among those currently affected and in the event of future public health crises.

查看原文本刊更多论文

在澳大利亚COVID-19大流行的第一年，过量的酒精引起的住院和死亡

自2019冠状病毒病发病以来，在美国和英国等地区，与酒精相关的危害有所增加。我们研究了酒精相关的危害是否随着澳大利亚的大流行而增加，以及这种影响是否因性别、年龄和酒精诊断类型而异。方法：采用自回归综合移动平均分析方法对2016年7月至2020年2月全国酒精导致的每月住院率和死亡率进行建模，并预测到2021年4月的反事实趋势。我们按性别、年龄和诊断估计了酒精引起的住院和死亡的平均每月人数的总体超额。结果：我们发现每月酒精引起的住院总人数（681人[95%预测区间481-872]），其中男性（437人[343-528]），女性（208人[50-355]），15- 34岁（144人[57-226]），35- 54岁（331人[2-636]），心血管、消化和内分泌疾病（164人[108-223]）和神经精神疾病（483人[236-721]）。总体而言，每月酒精导致的死亡人数过多（13人[4-21]），男性（10人[0-19]），女性（4人[1-7]），35至54岁的人群（8人[5-11]），心血管、消化和内分泌疾病（10人[2-18]）和中毒（2人[0-4]）。讨论和结论：澳大利亚各地因酒精引起的住院和死亡人数增加，表明有必要继续监测COVID-19大流行的长期影响，并制定战略，以尽量减少当前受影响人群和未来公共卫生危机时的进一步伤害。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drug and alcohol review SUBSTANCE ABUSE-

CiteScore

4.80

自引率

10.50%

发文量

151

期刊介绍： Drug and Alcohol Review is an international meeting ground for the views, expertise and experience of all those involved in studying alcohol, tobacco and drug problems. Contributors to the Journal examine and report on alcohol and drug use from a wide range of clinical, biomedical, epidemiological, psychological and sociological perspectives. Drug and Alcohol Review particularly encourages the submission of papers which have a harm reduction perspective. However, all philosophies will find a place in the Journal: the principal criterion for publication of papers is their quality.